PIII Financial Statements

Balance sheet, income statement, cash flow, and dividends for P3 Health Partners Inc (PIII).


$80.70M Market Cap.

As of 03/28/2025 5:00 PM ET (MRY) • Disclaimer

PIII Market Cap. (MRY)


PIII Shares Outstanding (MRY)


PIII Assets (MRY)


Total Assets

$783.42M

Total Liabilities

$633.89M

Total Investments

$0

PIII Income (MRY)


Revenue

$1.50B

Net Income

-$135.85M

Operating Expense

$208.04M

PIII Cash Flow (MRY)


CF Operations

-$110.13M

CF Investing

$14.53M

CF Financing

$98.77M

PIII Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2020

$0

-

0%

0%

-

2019

$0

-

-

0%

-

PIII Balance Sheet (MRY)


Metric

2024

2023

2022

2020

Total Assets

$783,420,000 (-9.01%)

$860,967,000 (-1.78%)

$876,571,000 (777.43%)

$99,902,252 (52.28%)

Assets Current

$184,140,000 (10.92%)

$166,017,000 (64.88%)

$100,692,000 (19.38%)

$84,347,633 (61.11%)

Assets Non-Current

$599,280,000 (-13.77%)

$694,950,000 (-10.43%)

$775,879,000 (4888.09%)

$15,554,619 (17.39%)

Goodwill & Intangible Assets

$574,350,000 (-13.86%)

$666,733,000 (-11.23%)

$751,050,000 (86115.80%)

$871,128 (17.54%)

Shareholders Equity

$75,936,000 (-46.57%)

$142,130,000 (2327.91%)

$5,854,000 (107.37%)

-$79,474,354 (-88.99%)

Property Plant & Equipment Net

$5,734,000 (-33.99%)

$8,686,000 (-1.73%)

$8,839,000 (-18.75%)

$10,878,829 (23.42%)

Cash & Equivalents

$44,102,000 (7.74%)

$40,934,000 (121.78%)

$18,457,000 (-53.75%)

$39,902,947 (21.27%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$3,804,662 (2.96%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$3,804,662 (2.96%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$125,213,000 (3.08%)

$121,470,000 (52.62%)

$79,592,000 (102.77%)

$39,251,904 (113.13%)

Trade & Non-Trade Payables

$319,096,000 (43.95%)

$221,664,000 (25.69%)

$176,357,000 (113.84%)

$82,470,300 (189.49%)

Accumulated Retained Earnings (Deficit)

-$503,193,000 (-36.98%)

-$367,344,000 (-18.67%)

-$309,545,000 (-145.20%)

-$126,242,225 (-48.23%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$166,163,000 (36.27%)

$121,941,000 (15.11%)

$105,937,000 (115.70%)

$49,112,403 (133.48%)

Debt Current

$65,000,000 (0%)

$0 (0%)

$0 (0%)

$89,988 (-94.48%)

Debt Non-Current

$101,163,000 (-17.04%)

$121,941,000 (15.11%)

$105,937,000 (116.10%)

$49,022,415 (152.61%)

Total Liabilities

$633,891,000 (48.35%)

$427,305,000 (20.74%)

$353,912,000 (142.48%)

$145,955,087 (97.29%)

Liabilities Current

$496,415,000 (65.82%)

$299,372,000 (23.88%)

$241,664,000 (166.69%)

$90,616,067 (66.04%)

Liabilities Non-Current

$137,476,000 (7.46%)

$127,933,000 (13.97%)

$112,248,000 (102.84%)

$55,339,020 (185.16%)

PIII Income Statement (MRY)


Metric

2024

2023

2022

2020

Revenues

$1,500,455,000 (18.48%)

$1,266,375,000 (20.67%)

$1,049,471,000 (116.14%)

$485,541,291 (232.80%)

Cost of Revenue

$1,613,070,000 (32.00%)

$1,222,035,000 (16.86%)

$1,045,763,000 (124.91%)

$464,973,779 (214.58%)

Selling General & Administrative Expense

$113,927,000 (-9.29%)

$125,595,000 (-22.65%)

$162,380,000 (195.81%)

$54,892,972 (47.46%)

Research & Development Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Expenses

$208,043,000 (-1.99%)

$212,270,000 (-86.43%)

$1,564,621,000 (2709.61%)

$55,688,144 (48.01%)

Interest Expense

$22,173,000 (38.71%)

$15,985,000 (40.17%)

$11,404,000 (14.38%)

$9,970,260 (186.57%)

Income Tax Expense

$4,387,000 (62.78%)

$2,695,000 (44.74%)

$1,862,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$310,378,000 (-66.49%)

-$186,426,000 (88.06%)

-$1,561,557,000 (-3340.95%)

-$45,381,576 (-5.74%)

Net Income to Non-Controlling Interests

-$174,529,000 (-35.66%)

-$128,653,000 (90.04%)

-$1,291,430,000 (-29883.95%)

-$4,307,071 (45.53%)

Net Income

-$135,849,000 (-135.14%)

-$57,773,000 (78.61%)

-$270,127,000 (-557.65%)

-$41,074,505 (-17.32%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$135,849,000 (-135.14%)

-$57,773,000 (78.61%)

-$270,127,000 (-557.65%)

-$41,074,505 (-17.32%)

Weighted Average Shares

$145,175,000 (52.99%)

$94,889,000 (128.21%)

$41,579,000 (504.79%)

$6,875,000

Weighted Average Shares Diluted

$146,998,000 (-50.10%)

$294,590,000 (608.51%)

$41,579,000 (504.79%)

$6,875,000

Earning Before Interest & Taxes (EBIT)

-$109,289,000 (-179.56%)

-$39,093,000 (84.78%)

-$256,861,000 (-725.81%)

-$31,104,245 (1.35%)

Gross Profit

-$112,615,000 (-353.98%)

$44,340,000 (1095.79%)

$3,708,000 (-81.97%)

$20,567,512 (1176.11%)

Operating Income

-$320,658,000 (-90.95%)

-$167,930,000 (89.24%)

-$1,560,913,000 (-4344.43%)

-$35,120,632 (11.17%)

PIII Cash Flow Statement (MRY)


Metric

2024

2023

2022

2020

Net Cash Flow from Investing

$14,525,000 (895.02%)

-$1,827,000 (76.37%)

-$7,733,000 (-144.24%)

-$3,166,148 (17.91%)

Net Cash Flow from Financing

$98,771,000 (-1.56%)

$100,332,000 (782.04%)

$11,375,000 (-67.28%)

$34,760,061 (-45.36%)

Net Cash Flow from Operations

-$110,128,000 (-44.85%)

-$76,028,000 (39.67%)

-$126,019,000 (-412.36%)

-$24,595,814 (13.05%)

Net Cash Flow / Change in Cash & Cash Equivalents

$3,168,000 (-85.91%)

$22,477,000 (118.37%)

-$122,377,000 (-1848.72%)

$6,998,099 (-77.77%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

-$5,500,000 (-4130.77%)

-$130,000 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

-$109,526 (95.45%)

Capital Expenditure

$0 (0%)

-$1,827,000 (18.18%)

-$2,233,000 (23.70%)

-$2,926,622 (-101.58%)

Issuance (Repayment) of Debt Securities

$58,852,000 (322.54%)

$13,928,000 (22.44%)

$11,375,000 (-67.44%)

$34,940,061 (2114.17%)

Issuance (Purchase) of Equity Shares

$33,000 (-99.96%)

$86,595,000 (0%)

$0 (0%)

-$180,000 (-100.29%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,752,000 (-3.80%)

$5,979,000 (-69.19%)

$19,404,000 (4236.34%)

$447,474 (-5.60%)

Depreciation Amortization & Accretion

$86,058,000 (-0.71%)

$86,675,000 (-0.70%)

$87,289,000 (10877.37%)

$795,172 (99.20%)

PIII Financial Metrics (MRY)


Metric

2024

2023

2022

2020

Gross Margin

-7.50% (-314.29%)

3.50% (775.00%)

0.40% (-90.48%)

4.20% (423.08%)

Profit Margin

-9.10% (-97.83%)

-4.60% (82.10%)

-25.70% (-202.35%)

-8.50% (64.58%)

EBITDA Margin

-1.50% (-139.47%)

3.80% (123.46%)

-16.20% (-161.29%)

-6.20% (70.89%)

Return on Average Equity (ROAE)

-106.60% (11.83%)

-120.90% (49.03%)

-237.20% (-450.89%)

67.60%

Return on Average Assets (ROAA)

-16.10% (-147.69%)

-6.50% (63.48%)

-17.80% (64.11%)

-49.60%

Return on Sales (ROS)

-7.30% (-135.48%)

-3.10% (87.35%)

-24.50% (-282.81%)

-6.40% (70.37%)

Return on Invested Capital (ROIC)

148.10% (-67.94%)

462.00% (-61.54%)

1201.10% (409.80%)

-387.70%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-0.24 (89.66%)

-2.31 (-716.61%)

-0.28

-

Price to Sales Ratio (P/S)

0.02 (-79.25%)

0.11 (45.21%)

0.07

-

Price to Book Ratio (P/B)

1.06 (-65.78%)

3.11 (-95.94%)

76.57

-

Debt to Equity Ratio (D/E)

8.35 (177.71%)

3.01 (-95.03%)

60.46 (3391.02%)

-1.84 (-4.43%)

Earnings Per Share (EPS)

-0.94 (-54.10%)

-0.61 (90.62%)

-6.5 (-948.39%)

-0.62 (16.22%)

Sales Per Share (SPS)

10.34 (-22.56%)

13.35 (-47.12%)

25.24 (-64.26%)

70.62

Free Cash Flow Per Share (FCFPS)

-0.76 (7.44%)

-0.82 (73.42%)

-3.08 (22.93%)

-4

Book Value Per Share (BVPS)

0.52 (-65.09%)

1.5 (962.41%)

0.14 (101.22%)

-11.56

Tangible Assets Book Value Per Share (TABVPS)

1.44 (-29.65%)

2.05 (-32.20%)

3.02 (-79.04%)

14.4

Enterprise Value Over EBIT (EV/EBIT)

-1 (92.31%)

-13 (-550.00%)

-2

-

Enterprise Value Over EBITDA (EV/EBITDA)

-6.77 (-163.65%)

10.63 (457.71%)

-2.97

-

Asset Turnover

1.78 (24.42%)

1.43 (106.78%)

0.69 (-88.19%)

5.87

Current Ratio

0.37 (-33.15%)

0.56 (33.09%)

0.42 (-55.21%)

0.93 (-2.92%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$110,128,000 (-41.45%)

-$77,855,000 (39.30%)

-$128,252,000 (-365.99%)

-$27,522,436 (7.45%)

Enterprise Value (EV)

$157,194,681 (-68.92%)

$505,823,207 (0.36%)

$504,027,421

-

Earnings Before Tax (EBT)

-$131,462,000 (-138.68%)

-$55,078,000 (79.47%)

-$268,265,000 (-553.12%)

-$41,074,505 (-17.32%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$23,231,000 (-148.82%)

$47,582,000 (128.06%)

-$169,572,000 (-459.48%)

-$30,309,073 (2.64%)

Invested Capital

-$165,284,000 (-584.94%)

-$24,131,000 (15.81%)

-$28,663,000 (-262.63%)

$17,624,513 (1215.18%)

Working Capital

-$312,275,000 (-134.17%)

-$133,355,000 (5.40%)

-$140,972,000 (-2148.92%)

-$6,268,434 (-182.30%)

Tangible Asset Value

$209,070,000 (7.64%)

$194,234,000 (54.74%)

$125,521,000 (26.75%)

$99,031,124 (52.68%)

Market Capitalization

$80,698,681 (-81.72%)

$441,455,207 (-1.51%)

$448,231,016

-

Average Equity

$127,471,500 (166.65%)

$47,805,500 (-58.02%)

$113,882,120 (287.42%)

-$60,763,239

Average Assets

$841,359,250 (-4.78%)

$883,560,000 (-41.68%)

$1,515,138,125 (1730.90%)

$82,753,689

Invested Capital Average

-$73,771,500 (-771.82%)

-$8,461,750 (60.43%)

-$21,385,214 (-366.58%)

$8,022,046

Shares

358,820,282 (14.61%)

313,088,799 (28.52%)

243,603,813 (593.53%)

35,125,000